The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis

BACKGROUND: The role of adjuvant chemotherapy (AC) in stage III rectal cancer (RC) has been argued based on evidence from its use in colon cancer. Previous trials have analysed disease-free and overall survivals as endpoints, rather than disease recurrence. This study compares the competing risks in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kheng-Seong, Chan, Charles, Rickard, Matthew John Francis Xavier, Keshava, Anil, Stewart, Peter, Chapuis, Pierre Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193597/
https://www.ncbi.nlm.nih.gov/pubmed/37198644
http://dx.doi.org/10.1186/s12957-023-03021-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193597/
https://www.ncbi.nlm.nih.gov/pubmed/37198644
http://dx.doi.org/10.1186/s12957-023-03021-w

Ejemplares similares